Leora Balsam to Coronary Artery Disease
This is a "connection" page, showing publications Leora Balsam has written about Coronary Artery Disease.
Connection Strength
1.852
-
Balsam LB, Gaudino M. Upcoming expert opinions on adult coronary surgery. J Thorac Cardiovasc Surg. 2021 Jul; 162(1):103-106.
Score: 0.592
-
Fryer ML, Balsam LB. Commentary: Coronary revascularization in younger patients: Lessons from real-world practice. J Thorac Cardiovasc Surg. 2022 02; 163(2):659-660.
Score: 0.554
-
Balsam LB, DeAnda A. To screen or not to screen, that is the question. Or is it? J Thorac Cardiovasc Surg. 2015 Jun; 149(6):1485-6.
Score: 0.387
-
Balsam LB, Mokhtari GK, Jones S, Peterson S, Hoyt EG, Kofidis T, Tanaka M, Cooke DT, Robbins RC. Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease. J Heart Lung Transplant. 2005 Jul; 24(7):827-32.
Score: 0.198
-
Tanaka M, Zwierzchoniewska M, Mokhtari GK, Terry RD, Balsam LB, Robbins RC, Fedoseyeva EV. Progression of alloresponse and tissue-specific immunity during graft coronary artery disease. Am J Transplant. 2005 Jun; 5(6):1286-96.
Score: 0.049
-
Tanaka M, Mokhtari GK, Balsam LB, Cooke DT, Kofidis T, Zwierzchonievska M, Robbins RC. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model. J Heart Lung Transplant. 2005 Apr; 24(4):446-53.
Score: 0.049
-
Tanaka M, Nakae S, Terry RD, Mokhtari GK, Gunawan F, Balsam LB, Kaneda H, Kofidis T, Tsao PS, Robbins RC. Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease. Blood. 2004 Dec 01; 104(12):3789-96.
Score: 0.012
-
Murata S, Miniati DN, Kown MH, Koransky ML, Balsam LB, Lijkwan MA, Martens JM, Robbins RC. Elevated cyclic adenosine monophosphate ameliorates ischemia-reperfusion injury in rat cardiac allografts. J Heart Lung Transplant. 2003 Jul; 22(7):802-9.
Score: 0.011